← SynDRA
CLOXACILLIN
SynDRA canonical compound SYN0002435 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | bacterial cell wall synthesis inhibitor |
| Indication | gram-positive bacterial infections |
| Disease area | infectious disease |
All known targets
- PBP2
- bla
- bla LAT-2
- bla; blaT-3; blaT-4;
- blaACC-4
- mecA
- pbp4
- pbpA
- pbpF
- sugE
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- pbp4 INHIBITOR
- mecA INHIBITOR
- pbpA INHIBITOR
- PBP2 INHIBITOR
- pbpF INHIBITOR
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01C · BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Cross-references
Synonyms
- Methocillin S
- cloxacillin sodium
- cloxacillin sodium salt
- cloxacillin benzathine
- Cloxacilline
- Cloxacilina
- Orbenin
- Chloroxacillin
- Clossacillina
- Cloxacillinum
- MCIPC
- Syntarpen
- Tegopen
- Clossacillina [DCIT]
- Cloxacillin sodium
- BRL 1621
- Cloxacilina [INN-Spanish]
- Cloxacillin (INN)
- Cloxacillin [INN:BAN]
- Cloxacilline [INN-French]
- Cloxacillinum [INN-Latin]
- Cloxapen (TN)
- Cloxapen (sodium monohydrate)
- Methylchlorphenylisoxazoryl-penicillin
- Novo-Cloxin
- Nu-Cloxi
- Orbenin (TN)
- Tegopen (sodium monohydrate)
- BRL-1621 (sodium monohydrate)
- P-25 (sodium monohydrate)
- [3-(O-CHLOROPHENYL)-5-METHYL-4-ISOXAZOLYL]PENICILLIN
- (2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- (2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- (3-(o-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin
- 6-(((3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
- 6-(3-(o-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid
- O6X5QGC2VB
- oxacillin sodium monohydrate impurity e (ep impurity)
Look up CLOXACILLIN in the interactive SynDRA portal →